top of page
AI for Drug Discovery, Biomarker Development and Advanced R&D Publicly Traded Companies Overview 2021
This Investment Digest is summarizing key players and observations in the stock market, focusing on the pharmaceutical Artificial Intelligence.
Here we have presented the information about key industry trends, 14 promising AI-driven publicly traded pharma companies, outlining major investment rounds and relevant R&D partnerships illustrating the industry traction and readiness of institutional investors (big pharma/biotech) to potentially acquire most successful AI-vendors, and conducted in-depth financial analysis of the AI in Pharma stock market, as well as presented our proprietary specialized thematic stock indices and porfolios.
bottom of page